Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Ilad Alavi Darazam and Mahdi Amirdosara.
Ilad Alavi Darazam
Connection Strength
0.769
Mahdi Amirdosara
  1. Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial. Int Immunopharmacol. 2021 Oct; 99:107969.
    View in: PubMed
    Score: 0.239
  2. An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial. Int Immunopharmacol. 2021 Oct; 99:107916.
    View in: PubMed
    Score: 0.238
  3. Post-mortem Histopathologic Findings of Vital Organs in Critically Ill Patients with COVID-19. Arch Iran Med. 2021 Feb 01; 24(2):144-151.
    View in: PubMed
    Score: 0.232
  4. Evaluation of the prophylactic effect of hydroxychloroquine on people in close-contact with patients with COVID-19. Pulm Pharmacol Ther. 2021 10; 70:102069.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.